文献速递甲状腺疾病

预防和治疗碘缺乏与甲状腺疾病的决策分析模型研究:系统综述概览

Decision-Analytic Modeling Studies in Prevention and Treatment of Iodine Deficiency and Thyroid Disorders: A Systematic Overview.
PubMed 文献 · Thyroid · 2020-02-26

该研究系统检索1985至2018年PubMed/MEDLINE、EMBASE、Tuft's成本效果分析注册库和NHS EED,纳入17项应用数学模型比较碘缺乏和甲状腺疾病不同预防或治疗策略的研究。多数研究发现筛查可能具有成本效果或节省成本,但治疗相关推荐因研究问题、人群和场景而异,且所有模型均未报告正式模型验证。

要点

  • 共纳入17项决策分析模型研究,其中11项评估筛查项目,5项聚焦治疗方式,1项关于一级预防。
  • 15项研究报告以质量调整生命年(QALYs)作为健康结局指标,全部研究均进行了成本效果分析。
  • 所有模型均未报告正式模型验证,结论依赖诸多假设,需谨慎解读。

核心结论

  • 多数决策分析模型研究结论为筛查可能具有成本效果甚至节省成本,但治疗相关推荐因研究问题、人群和场景而异。
  • 尚无模型在人群层面评估一级预防项目。
  • 研究结论(如预防可节省成本)依赖诸多假设,需谨慎解读。

研究设计与样本

  • 系统综述:检索PubMed/MEDLINE、EMBASE、Tuft's成本效果分析注册库和NHS EED,纳入1985至2018年发表的、应用数学决策分析模型比较碘缺乏和甲状腺疾病不同预防或治疗策略并评估患者相关健康结局的研究,最终纳入17项研究。

主要发现

  • 11项研究评估筛查项目(主要针对新生儿和孕妇),5项研究聚焦治疗方式(Graves病、毒性甲状腺腺瘤),1项研究关于一级预防(碘补充对子代的影响)。
  • 7项研究基于马尔可夫状态转换模型,9项研究基于决策树模型,1项研究结合了初始决策树和长期马尔可夫状态转换模型。
  • 分析时间跨度从1年到终生不等;15项研究以QALYs作为健康结局指标;全部研究均进行了成本效果分析。
  • 多数研究作者结论为筛查可能具有成本效果甚至节省成本;治疗相关推荐异质性较大,取决于具体研究问题、人群和场景。

关键数值与推荐

  • 所有纳入模型均未报告正式模型验证。
  • 多数研究在美国医疗背景下进行(n=7)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 所有模型均未报告正式模型验证。
  • 研究结论(如预防可节省成本)依赖诸多假设,需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Prevention and treatment of iodine deficiency-related diseases remain an important public health challenge. Iodine deficiency can have severe health consequences, such as cretinism, goiter, or other thyroid disorders, and it has economic implications. Our aim was to give an overview of studies applying decision-analytic modeling to evaluate the effectiveness and/or cost-effectiveness of iodine deficiency-related prevention strategies or treatments related to thyroid disorders. Methods: We performed a systematic literature search in PubMed/MEDLINE (Medical Literature Analysis and Retrieval System Online), EMBASE (Excerpta Medica Database), Tuft's Cost-Effectiveness Analysis Registry, and National Health System Economic Evaluation Database (NHS EED) to identify studies published between 1985 and 2018 comparing different prevention or treatment strategies for iodine deficiency and thyroid disorders by applying a mathematical decision-analytic model. Studies were required to evaluate patient-relevant health outcomes (e.g., remaining life years, quality-adjusted life years [QALYs]). Results: Overall, we found 3950 studies. After removal of duplicates, abstract/title, and full-text screening, 17 studies were included. Eleven studies evaluated screening programs (mainly newborns and pregnant women), five studies focused on treatment approaches (Graves' disease, toxic thyroid adenoma), and one study was about primary prevention (consequences of iodine supplementation on offspring). Most of the studies were conducted within the U.S. health care context (n = 7). Seven studies were based on a Markov state-transition model, nine studies on a decision tree model, and in one study, an initial decision tree and a long-term Markov state-transition model were combined. The analytic time horizon ranged from 1 year to lifetime. QALYs were evaluated as health outcome measure in 15 of the included studies. In all studies, a cost-effectiveness analysis was performed. None of the models reported a formal model validation. In most cases, the authors of the modeling studies concluded that screening is potentially cost-effective or even cost-saving. The recommendations for treatment approaches were rather heterogeneous and depending on the specific research question, population, and setting. Conclusions: Overall, we predominantly identified decision-analytic modeling studies evaluating specific screening programs or treatment approaches; however, there was no model evaluating primary prevention programs on a population basis. Conclusions deriving from these studies, for example, that prevention is cost-saving, need to be carefully interpreted as they rely on many assumptions.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Rochau U, Qerimi Rushaj V, Schaffner M, et al. Decision-Analytic Modeling Studies in Prevention and Treatment of Iodine Deficiency and Thyroid Disorders: A Systematic Overview. Thyroid. 2020. PMID: 31964247. doi:10.1089/thy.2018.0776

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。